Currently, there are 923.00M common shares owned by the public and among those 918.14M shares have been available to trade.
The company’s stock has a 5-day price change of -9.93% and -7.49% over the past three months. UNH shares are trading 4.40% year to date (YTD), with the 12-month market performance up to 0.02% higher. It has a 12-month low price of $436.38 and touched a high of $630.73 over the same period. UNH has an average intraday trading volume of 3.28 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -8.30%, -6.25%, and 2.23% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Unitedhealth Group Inc (NYSE: UNH) shares accounts for 89.62% of the company’s 923.00M shares outstanding.
It has a market capitalization of $480.17B and a beta (3y monthly) value of 0.59. The stock’s trailing 12-month PE ratio is 35.70, while the earnings-per-share (ttm) stands at $15.39. The company has a PEG of 2.75 and the debt-to-equity ratio at 0.83. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.94% over the week and 2.49% over the month.
Earnings per share for the fiscal year are expected to increase by 9.90%, and 8.35% over the next financial year. EPS should shrink at an annualized rate of 13.00% over the next five years, compared to 14.37% over the past 5-year period.
KeyBanc Capital Markets coverage for the Unitedhealth Group Inc (UNH) stock in a research note released on October 11, 2024 offered a Overweight rating with a price target of $675. Jefferies was of a view on July 17, 2024 that the stock is Buy, while RBC Capital Mkts gave the stock Outperform rating on July 17, 2024, issuing a price target of $555- $615. HSBC Securities on their part issued Buy rating on June 05, 2024.
